drugset
drugset / Trial / NCT01888757

Lamotrigine Extended-Release Tablets 50 mg Under Fed Condition

NCT01888757 ↗

Phase 1 Completed 62 enrolled Dr. Reddy's Laboratories Limited
RandomizedCrossoverOpen-labelTreatment

Summary

This is an open label, randomised, balanced, two-treatment, two-period, two-sequence, single dose, crossover, oral bioequivalence study.

Timeline

Start
2010-09
Primary completion
2010-09
Completion
2010-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Lamotrigine Small molecule 50 mg Oral

Indications

No indication recorded.